These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 1764573)

  • 1. Monitoring hemostasis in the perioperative period: anticoagulation control.
    Reich DL
    J Cardiothorac Vasc Anesth; 1991 Dec; 5(6 Suppl 1):4-7. PubMed ID: 1764573
    [No Abstract]   [Full Text] [Related]  

  • 2. Monitoring anticoagulation and hemostasis in cardiac surgery.
    Shore-Lesserson L
    Anesthesiol Clin North Am; 2003 Sep; 21(3):511-26. PubMed ID: 14562563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Coagulation profiles during cardiac surgery].
    Bitkova EE; Zvereva NIu; Khvatov VB; Chumakov MV; Timerbaev VKh; Dublev AV; Redkoborodyĭ AV
    Anesteziol Reanimatol; 2014; (1):14-7. PubMed ID: 24749302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence based coagulation monitors: heparin monitoring, thromboelastography, and platelet function.
    Shore-Lesserson L
    Semin Cardiothorac Vasc Anesth; 2005 Mar; 9(1):41-52. PubMed ID: 15735843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monitoring of hemostasis in cardiac surgical patients: impact of point-of-care testing on blood loss and transfusion outcomes.
    Despotis GJ; Joist JH; Goodnough LT
    Clin Chem; 1997 Sep; 43(9):1684-96. PubMed ID: 9299961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methods for monitoring hemostasis during and following cardiac surgery.
    Huffman SM; Stammers AH
    Int Anesthesiol Clin; 1996; 34(2):123-39. PubMed ID: 8799750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postoperative hemostasis.
    Ellison N; Campbell FW; Jobes DR
    Semin Thorac Cardiovasc Surg; 1991 Jan; 3(1):33-8. PubMed ID: 2015316
    [No Abstract]   [Full Text] [Related]  

  • 8. Viscoelastic blood coagulation measurement with Sonoclot predicts postoperative bleeding in cardiac surgery after heparin reversal.
    Bischof DB; Ganter MT; Shore-Lesserson L; Hartnack S; Klaghofer R; Graves K; Genoni M; Hofer CK
    J Cardiothorac Vasc Anesth; 2015; 29(3):715-22. PubMed ID: 25864405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anticoagulation and the GP patient.
    Lloyd JV; Rodgers SE
    Aust Fam Physician; 1994 Aug; 23(8):1476-81. PubMed ID: 7980147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo and in vitro evaluation of the heparin management test versus the activated coagulation time for monitoring anticoagulation level in aprotinin-treated patients during cardiac surgery.
    Kim YS; Murkin JM; Adams SJ
    Heart Surg Forum; 2004; 7(6):E599-604. PubMed ID: 15769695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monitoring of intraoperative heparinization and blood loss following cardiopulmonary bypass surgery.
    Babka R; Colby C; El-Etr A; Pifarré R
    J Thorac Cardiovasc Surg; 1977 May; 73(5):780-2. PubMed ID: 850438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of continuous elimination methods on the hemostatic profile of a cardiac surgery patient monitored using thromboelastography.
    Zuščich O; Hájek R; Ševčík P; Lonský V; Zapletalová J
    Int J Artif Organs; 2016 May; 39(3):106-13. PubMed ID: 27102694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Monitoring of heparin therapy during extracorporeal bypass: what are the remaining questions?].
    Jude B; Lasne D; Mouton C; de Moerloose P; ; ;
    Ann Fr Anesth Reanim; 2004 Jun; 23(6):589-96. PubMed ID: 15234724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. On-site coagulation monitoring does not affect hemostatic outcome after cardiac surgery.
    Capraro L; Kuitunen A; Salmenperä M; Kekomäki R
    Acta Anaesthesiol Scand; 2001 Feb; 45(2):200-6. PubMed ID: 11167166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Problems in hemostasis during open heart urgery. VII. Changes in fibrinogen concentration during and after cardiopulmonary bypass with particular reference to the effect of heparin neutralization on fibrinogen.
    Gans H; Castaneda AR
    Ann Surg; 1967 Apr; 165(4):551-6. PubMed ID: 6021455
    [No Abstract]   [Full Text] [Related]  

  • 16. Quantitative measurement of heparin in comparison with conventional anticoagulation monitoring and the risk of thrombotic events in adults on extracorporeal membrane oxygenation.
    Chu DC; Abu-Samra AG; Baird GL; Devers C; Sweeney J; Levy MM; Muratore CS; Ventetuolo CE
    Intensive Care Med; 2015 Feb; 41(2):369-70. PubMed ID: 25465907
    [No Abstract]   [Full Text] [Related]  

  • 17. Monitoring activated clotting time for combined heparin and aprotinin application: in vivo evaluation of a new aprotinin-insensitive test using Sonoclot.
    Ganter MT; Monn A; Tavakoli R; Genoni M; Klaghofer R; Furrer L; Honegger H; Hofer CK
    Eur J Cardiothorac Surg; 2006 Aug; 30(2):278-84. PubMed ID: 16828293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perioperative coagulation monitoring.
    Felfernig M; Boehm D; Hartmann T; Blaicher A
    Acta Anaesthesiol Scand Suppl; 1997; 111():215-6. PubMed ID: 9421018
    [No Abstract]   [Full Text] [Related]  

  • 19. More effective suppression of hemostatic system activation in patients undergoing cardiac surgery by heparin dosing based on heparin blood concentrations rather than ACT.
    Despotis GJ; Joist JH; Hogue CW; Alsoufiev A; Joiner-Maier D; Santoro SA; Spitznagel E; Weitz JI; Goodnough LT
    Thromb Haemost; 1996 Dec; 76(6):902-8. PubMed ID: 8972009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intraoperative monitoring and postoperative reevaluation of hemostasis in orthotopic liver transplantation.
    Azad SC; Kratzer MA; Groh J; Welte M; Haller M; Pratschke E
    Semin Thromb Hemost; 1993; 19(3):233-7. PubMed ID: 8362253
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.